Mobile navigation
Tests
Tests for Providers
Clinical Tests
Discover
Connect With Us
Tests for Patients
Cancer Tests
Learn
Need Help?
Resources
Resources for Providers
Resource Centers
Explore
Resources for Patients
Innovation
Technology
Research Use Only
Company
About Us
News & Events
Connect
Investors
Welcome
Financials
Governance
Investor Resources
Search
The Afirma GRID research-use-only data resource is shared with the research community to accelerate scientific discoveries in thyroid nodules and thyroid cancer.
The Afirma GRID (Genomic Resource for Intelligent Discovery) proprietary research-use-only database is designed to help clinicians advance the understanding of thyroid nodules and thyroid cancer at the molecular level.
The Afirma GRID data resource enables researchers and clinicians to uncover new insights into thyroid nodule and thyroid cancer biology by providing access to:
Important
GRID data is for research use only and is not intended to guide patient management.
An optional research-use-only report that provides a subset of the signatures is available when ordering Afirma GSC
A research data set of the signatures database for patients tested at your practice/institution
A custom collaboration across our data set around mutually defined research goals designed to advance the science
Research Report
Watch Dr. Joshua Klopper, Veracyte Medical Director for Endocrinology, provide a page-by-page overview of the Afirma GRID research-use-only report.
Afirma GRID data access may require research collaboration agreements. Our medical and scientific teams work with qualified researchers to:
Research outcomes published in peer-reviewed journals contribute to scientific understanding but do not constitute clinical recommendations.
Advancing Thyroid Nodule Molecular Science
Explore a comprehensive compilation of research featuring:
No. Afirma GRID is not for patient management or clinical decision-making. It is for research use only and must be selected separately on the Test Requisition Form (TRF) or ordering portal by checking the appropriate box.
No. Afirma GRID is delivered as a separate research-use-only report from the clinical Afirma GSC test report and must be selected separately on the Test Requisition Form (TRF) or ordering portal by checking the appropriate box.
Once the request is received and approved, data delivery typically takes up to four weeks.
Learn how Afirma GSC helps clinicians confidently guide treatment decisions for thyroid nodules.
Veracyte publications and references showcasing discoveries and advancements.
View scientific publications, videos, FAQS, and more.
A novel diagnostics platform helping unlock deeper cancer insights.
This webpage contains forward-looking statements. These forward-looking statements involve risks and uncertainties. For more information, click here.